Hologic, Inc (HOLX) is gearing up for another turning point as it hit the volume of 1.65 million

Hologic, Inc (NASDAQ: HOLX) kicked off on Tuesday, up 0.34% from the previous trading day, before settling in for the closing price of $65.01. Over the past 52 weeks, HOLX has traded in a range of $62.69-$84.67.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

During the last 5-year period, the sales growth of Healthcare Sector giant was 6.10%. While this was happening, its average annual earnings per share was recorded 4.63%. With a float of $222.50 million, this company’s outstanding shares have now reached $225.56 million.

Let’s determine the extent of company efficiency that accounts for 7063 employees. In terms of profitability, gross margin is 56.18%, operating margin of 23.94%, and the pretax margin is 22.81%.

Hologic, Inc (HOLX) Insider Activity

Our next focus will be how large-scale investors are participating in this stock of the Medical Instruments & Supplies Industry. The insider ownership of Hologic, Inc is 0.84%, while institutional ownership is 103.12%. The most recent insider transaction that took place on Dec 04 ’24, was worth 1,897,482. In this transaction Chief Operating Officer of this company sold 24,856 shares at a rate of $76.34, taking the stock ownership to the 27,957 shares. Before that another transaction happened on Dec 04 ’24, when Company’s Officer proposed sale 24,856 for $76.34, making the entire transaction worth $1,897,484.

Hologic, Inc (HOLX) Earnings and Forecasts

Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.1 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 4.63% per share during the next fiscal year.

Hologic, Inc (NASDAQ: HOLX) Trading Performance Indicators

Take a look at Hologic, Inc’s (HOLX) current performance indicators. Last quarter, stock had a quick ratio of 2.78. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.62. Likewise, its price to free cash flow for the trailing twelve months is 12.95.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 3.16, a number that is poised to hit 1.02 in the next quarter and is forecasted to reach 4.65 in one year’s time.

Technical Analysis of Hologic, Inc (HOLX)

Looking closely at Hologic, Inc (NASDAQ: HOLX), its last 5-days average volume was 1.91 million, which is a drop from its year-to-date volume of 2.43 million. As of the previous 9 days, the stock’s Stochastic %D was 75.10%. Additionally, its Average True Range was 1.53.

During the past 100 days, Hologic, Inc’s (HOLX) raw stochastic average was set at 11.68%, which indicates a significant decrease from 24.43% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 46.08% in the past 14 days, which was higher than the 25.36% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $69.99, while its 200-day Moving Average is $76.28. However, in the short run, Hologic, Inc’s stock first resistance to watch stands at $65.53. Second resistance stands at $65.84. The third major resistance level sits at $66.23. If the price goes on to break the first support level at $64.83, it is likely to go to the next support level at $64.44. Should the price break the second support level, the third support level stands at $64.13.

Hologic, Inc (NASDAQ: HOLX) Key Stats

The company with the Market Capitalisation of 14.64 billion has total of 224,390K Shares Outstanding. Its annual sales at the moment are 4,030 M in contrast with the sum of 789,500 K annual income. Company’s last quarter sales were recorded 1,022 M and last quarter income was 201,000 K.